Sagent Pharmaceuticals has appointed Mark Kessel as senior advisor to the firm.  Kessel, a co-founder of Symphony Capital, will assist Sagent's expanding healthcare practice from its New York office.

Before founding Symphony Capital in 2002, Kessel was the managing partner of Shearman & Sterling, where he was responsible for the day-to-day operations of the firm.  He also has extensive experience in M&A, public and private financings, as well as other advisory assignments. Kessel continues to be a partner of Symphony Capital, and is a director of Dynavax Technologies Corporation and OXiGENE.